Ketorolac Pregnancy Safety Calculator
Enter your gestational age to see ketorolac safety recommendations based on medical guidelines.
Enter your gestational age to see safety information.
Ketorolac is a potent non‑steroidal anti‑inflammatory drug (NSAID) prescribed for short‑term relief of moderate to severe pain. It works by blocking the enzyme cyclooxygenase, which reduces prostaglandin production and thus eases pain and inflammation. While effective for post‑operative discomfort, its use during pregnancy raises many questions, especially for expectant mothers who need fast‑acting pain relief. This guide breaks down everything you need to know about ketorolac pregnancy safety, risks by trimester, and safer alternatives.
How Ketorolac Works
Ketorolac belongs to the NSAIDs family, a class of drugs that inhibit cyclooxygenase (COX‑1 and COX‑2). By reducing prostaglandins, the drug lowers pain signals, fever, and platelet aggregation. Unlike acetaminophen, which works mainly in the brain, NSAIDs act directly at sites of inflammation, making them valuable for dental surgery, orthopedic procedures, and severe musculoskeletal pain.
Pregnancy Safety Classification
Regulatory bodies use specific categories to describe drug safety in pregnancy. In the United States, the Food and Drug Administration (FDA) employs the FDA Pregnancy Category system (now replaced by the Pregnancy and Lactation Labeling Rule, but still referenced). Ketorolac is classified as **Category C** for the first two trimesters and **Category D** after 20 weeks, meaning animal studies have shown risk and there are no adequate human studies, or risks outweigh benefits.
Risks by Trimester
Understanding how the drug interacts with a developing fetus is key.
- First Trimester (0‑12 weeks): The embryo is forming critical organs. NSAID exposure, including ketorolac, may increase the chance of miscarriage or congenital heart defects, though data are limited.
- Second Trimester (13‑27 weeks): The fetus starts to rely on prostaglandins for kidney development. Placental Transfer of ketorolac occurs, potentially leading to reduced fetal urine output and oligohydramnios.
- Third Trimester (28 weeks‑birth): NSAIDs can cause premature closure of the ductus arteriosus, a vital blood vessel that bypasses the lungs before birth. This may result in fetal heart strain or pulmonary hypertension.
Because of these risks, most obstetric guidelines advise avoiding ketorolac after 20 weeks gestation unless the benefit is absolutely necessary.

Common Side Effects for Expectant Mothers
Even short courses (≤5 days) can produce maternal side effects that indirectly affect the pregnancy.
- Gastrointestinal bleeding - heightened by increased blood volume during pregnancy.
- Kidney impairment - NSAIDs reduce renal blood flow, which can worsen pre‑existing hypertension or lead to fluid retention.
- Increased bleeding risk - ketorolac inhibits platelet aggregation, potentially complicating labor or delivery.
Alternatives for Pain Relief During Pregnancy
If you need pain control, consider options with a stronger safety record.
Drug | FDA Category (Pregnancy) | Trimester Guidance | Key Risks |
---|---|---|---|
Acetaminophen | Category B | Generally safe throughout pregnancy | Rare liver toxicity at high doses |
Ibuprofen | Category D after 20 weeks | Avoid after 20 weeks; short‑term use possible before then | Fetal renal issues, ductus arteriosus closure |
Ketorolac | Category C (1‑2 trimesters), D (3rd) | Not recommended after 20 weeks; limited use early only if essential | Bleeding, renal impairment, fetal heart complications |
Acetaminophen remains the first‑line recommendation for most pregnant patients because it does not interfere with prostaglandin pathways. If a stronger anti‑inflammatory effect is required, discuss low‑dose ibuprofen before 20 weeks with your obstetrician.

Breastfeeding Considerations
After delivery, many mothers wonder whether ketorolac is safe while nursing. The drug does pass into breast milk in low concentrations. According to the American Academy of Pediatrics, occasional short courses (<5 days) are unlikely to cause harm to the infant, but prolonged use is discouraged. If you need ongoing pain relief, switch to acetaminophen or a prescribed opioid with known safety data.
When to Talk to Your Healthcare Provider
Never start or continue ketorolac on your own during pregnancy. Schedule a consultation if you:
- Experience persistent pain that OTC options do not control.
- Have a history of kidney disease, hypertension, or clotting disorders.
- Are past 20 weeks gestation and your doctor suggests any NSAID.
- Are unsure about medication interactions with prenatal vitamins or other prescriptions.
A thorough risk‑benefit analysis will consider the dose, duration, and your overall health. Your provider may order an ultrasound to check amniotic fluid levels if NSAID exposure is suspected.
Frequently Asked Questions
Can I take a single dose of ketorolac if I’m in my second trimester?
A one‑time dose may be permissible if the pain is severe and alternatives fail, but only under close medical supervision. The doctor will weigh the short‑term benefit against potential fetal kidney effects.
What symptoms should make me stop taking ketorolac immediately?
Seek emergency care if you notice unexplained vaginal bleeding, severe stomach pain, sudden swelling, or signs of an allergic reaction such as rash or difficulty breathing.
Is it safe to use ketorolac during labor?
No. NSAIDs can increase bleeding risk during delivery and may affect the newborn’s cardiovascular transition. Epidural analgesia or approved opioids are preferred.
How long should I wait after giving birth before taking ketorolac?
If you are not breastfeeding, most providers allow ketorolac after the first 24‑48 hours post‑delivery. If you are nursing, discuss timing with your pediatrician; many recommend waiting at least 12 hours.
Are there any drug interactions I should watch for?
Ketorolac can amplify the effects of anticoagulants (warfarin, heparin), other NSAIDs, and certain antihypertensives. Combining it with selective serotonin reuptake inhibitors (SSRIs) may increase bleeding risk.
Bottom line: ketorolac can be a helpful short‑term painkiller, but its safety window during pregnancy is narrow. Always partner with your OB‑GYN or pharmacist to choose the safest option for you and your baby.
Eli Soler Caralt
October 21, 2025 AT 18:48Ah, the delicate dance of prostaglandins and fetal development feels akin to a tragic sonnet, where ketorolac waltzes in with reckless grace 🌟. While the literature whispers caution, one might muse that the very act of silencing pain becomes a philosophical paradox for the expectant soul.